Faculty Articles
Anticoagulation With Edoxaban: When to Worry
Publication Title
Medscape
Publisher
Medscape
Publication Date
3-2-2016
Keywords
edoxaban, embolism, inhibitor, nonvalvular atrial fibrillation (NVAF), stroke
Abstract
Edoxaban, a reversible and direct inhibitor of factor Xa, is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
NSUWorks Citation
Singh-Franco, Devada, "Anticoagulation With Edoxaban: When to Worry" (2016). Faculty Articles. 372.
https://nsuworks.nova.edu/hpd_corx_facarticles/372